Balabad, Bb Girl .
HRN: 22-65-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
AMPICILLIN 1GM (VIAL)
03/30/2023
04/07/2023
IV
150mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes